About Carigent Therapeutics
Carigent Therapeutics is a company based in United States founded in 2007.. Carigent Therapeutics offers products and services including Proprietary Platform and Therapeutic Agents.
- Headquarter United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Carigent Technologies
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$204.34 K (USD), Grant
Sep 15, 2016
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Carigent Therapeutics
Carigent Therapeutics offers a comprehensive portfolio of products and services, including Proprietary Platform and Therapeutic Agents. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A platform is utilized for the development of therapeutic agents, including controlled release and targeting features.
Agents are developed for various applications, incorporating surface ligands and multiple components from FDA-approved materials.
Funding Insights of Carigent Therapeutics
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $204,344
-
First Round
First Round
(09 Nov 2007)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2016 | Amount | Grant - Carigent Therapeutics | Valuation |
investors |
|
| Jan, 2016 | Amount | Grant - Carigent Therapeutics | Valuation |
investors |
|
| Sep, 2008 | Amount | Grant - Carigent Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Carigent Therapeutics
Carigent Therapeutics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Carigent Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Carigent Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Carigent Therapeutics Comparisons
Competitors of Carigent Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Carigent Therapeutics
When was Carigent Therapeutics founded?
Carigent Therapeutics was founded in 2007.
Where is Carigent Therapeutics located?
Carigent Therapeutics is headquartered in United States.
What does Carigent Therapeutics do?
Carigent Therapeutics was founded in 2007 and is based in the United States. Operations focus on the biotechnology sector, where next-generation therapeutic agents are created using a proprietary controlled-release platform. This technology supports controlled release of agents, surface ligand attachment, targeted delivery to specific sites, and integration of multiple agents into a single FDA-approved vehicle. Versatility is provided for developing various therapeutics.
What products or services does Carigent Therapeutics offer?
Carigent Therapeutics offers Proprietary Platform and Therapeutic Agents.
Who are Carigent Therapeutics's investors?
Carigent Therapeutics has 2 investors. Key investors include HHS, and National Science Foundation.